Related Experiment Videos
Cardiovascular risk factors in minorities
John C LaRosa1, Clinton D Brown
1Office of the President, SUNY Downstate Medical Center, Brooklyn, NY 11203-2098, USA. jclarosa@downstate.edu
Insights
Interventions for hypertension and hyperlipidemia are vital for preventing atherosclerosis. However, risk factor prevalence and intervention effectiveness may differ in minority populations, necessitating further research.
Area of Science:
- Cardiovascular Medicine
- Public Health
- Health Disparities
Background:
- Atherosclerosis progression and clinical outcomes are influenced by major risk factors like hypertension and hyperlipidemia.
- Limited data exists on the prevalence and impact of atherosclerosis risk factors within minority populations.
- Minority inclusion in clinical trials is often insufficient to assess differential intervention benefits.
Purpose of the Study:
- To review the prevalence of atherosclerosis risk factors in minority populations.
- To assess the inclusion of minorities in clinical trials for cardiovascular risk factor intervention.
- To highlight potential differences in risk factor profiles and intervention responses among diverse groups.
Main Methods:
- Literature review of recent studies on atherosclerosis risk factors in minority populations.
- Analysis of data on the prevalence of established and novel risk predictors.
- Examination of minority participation rates in relevant clinical trials.
Main Results:
- Significant variations in the prevalence of risk factors exist across different minority groups.
- African descendants show higher rates of obesity, elevated blood pressure, and premature coronary death.
- Certain Hispanic populations exhibit higher levels of triglycerides, low high-density lipoproteins, and diabetes compared to whites.
- Minorities are underrepresented in clinical trials, limiting the assessment of intervention efficacy.
Conclusions:
- Risk factor intervention is crucial for all populations, including minorities.
- Differences in risk factor prevalence among minority groups warrant tailored approaches.
- Further research is needed to determine if intervention responses vary qualitatively or quantitatively across different racial and ethnic groups.
Abstract:
Recent clinical trials have confirmed the value of intervention on major risk factors, particularly hypertension and hyperlipidemia, in preventing the progression and clinical sequelae of atherosclerosis. Less is known about the prevalence and impact of atherosclerosis risk factors in minorities. A review of recent literature reporting the prevalence of established and new predictors of atherosclerotic events in minority populations and the inclusion of minorities in clinical trials is presented. The prevalence of risk factors differs considerably in minority populations. The role of "premature" coronary death and the level of some risk factors, particularly obesity and blood pressure in African descendants and high triglycerides, low high-density lipoproteins, and diabetes in some Hispanics, is higher than in whites. With few exceptions, however, minorities have not been included in clinical trials in sufficient numbers to determine whether significant differences in the benefit of risk factor intervention exists. Prevalence of key risk factors differs among minority groups. Risk factor intervention should be pursued in minority groups but with the understanding that clinical trials have not ruled out the possibility of qualitative or quantitative differences in response rates among different groups.
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease IV: Preventive Measures
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Factors affecting Blood pressure
Physiological Factors:
Atherosclerosis III: Management
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...